Sandip Kapadia

Sandip Kapadia, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Harmony Biosciences Holdings, Inc. and Passage BIO, Inc. The record holds 15 filings, for trades running from 1 December 2022 to 26 January 2026.

Sales make up the whole of the open-market record (6 sales, €1.7M). Besides market trades, the filings include 9 option exercises. Since January 2026: no purchases and 2 sales on the market.

Most recently, on 28 January 2026, the filings show an open-market sale worth €117k in Harmony Biosciences Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.